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Abstract 
 
     High accuracy of blood glucose prediction over the 
long term is essential for preventative diabetes 
management. The emerging closed-loop insulin delivery 
system such as the artificial pancreas system (APS) 
provides opportunities for improved glycaemic control 
for patients with type 1 diabetes. Existing blood glucose 
studies are proven effective only within 30 minutes but 
the accuracy deteriorates drastically when the 
prediction horizon increases to 45 minutes and 60 
minutes. Deep learning, especially for long short term 
memory (LSTM) and its variants have recently been 
applied in various areas to achieve state-of-the-art 
results in tasks with complex time series data. In this 
study, we present deep LSTM based models that are 
capable of forecasting long term blood glucose levels 
with improved prediction and clinical accuracy. We 
evaluate our approach using 20 cases(878,000 glucose 
values) from Open Source Artificial Pancreas System 
(OpenAPS).  On 30-minutes and 45-minutes prediction, 
our Stacked-LSTM achieved the best performance with 
Root-Mean-Square-Error (RMSE) marks 11.96 & 15.81 
and Clark-Grid-ZoneA marks 0.887 & 0.784. In terms 
of 60-minutes prediction, our ConvLSTM has the best 
performance with RMSE = 19.6 and Clark-Grid-
ZoneA=0.714. Our models outperform existing methods 
in both prediction and clinical accuracy. This research 
can hopefully support patients with type 1 diabetes to 
better manage their behavior in a more preventative 
way and can be used in future real APS context. 
 
 
 
 
 
 
1. Introduction  
 
Type 1 Diabetes is an autoimmune disease that causes 
the insulin-producing beta cells in the pancreas to be 
destroyed, preventing the body from being able to 
produce enough insulin to adequately regulate blood 
glucose levels [1]. Estimating and predicting blood 
glucose in both the short-term and long-term are 
essential for effective management of diabetes. The 
traditional approach to managing Type 1 diabetes relies 
on patients’ own estimation of insulin amount which 
often leads to hyperglycemia or hypoglycemia due to 
incorrect estimation [2]. The artificial pancreas, or 
closed-loop insulin delivery system is emerging to 
continuously monitors blood sugar levels, calculates the 
amount of insulin required (through a device such as a 
tablet or mobile phone), and automatically delivers 
insulin through a pump [3]. Although the insulin pump 
automatically adjusts basal insulin in existing FDA 
approved hybrid closed-loop system [4], accurate 
prediction on long-term blood glucose level under the 
context of closed-loop artificial pancreas system (APS) 
is of high importance because it is essential for 
preventative blood glucose control and to better guide 
meals intake, exercise and support patients planning 
daily activities further ahead (e.g. 1 hour). This will 
allow patients to take actions ahead of time in order to 
the occurrence of adverse glycaemic events. 
    Existing blood glucose prediction research focuses on 
short term predictions such as 15 minutes to 30 minutes 
but the performance of the prediction models dropped 
dramatically when it comes to long term predictions 
such as 45 min to 1 hour [5]. The state-of-the-art deep 
learning models such as long short term memory 
(LSTM) and its variants demonstrate strong capabilities 
in long term forecasting [6]. In this research, we aim to 
develop a long-term blood glucose forecasting model 
based on convolutional-LSTM and compare our model 
with other LSTM models and existing methods used in 
blood glucose prediction.   
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Figure 1 Artificial Pancreas System 
 
The remainder of this article is structured as follows. 
The related works are presented in Section 2, variations 
of LSTM are introduced in Section 3, dataset and 
training process are in Section 4, evaluation methods in 
Section 5, comments on results in Section 6, and 
conclusions in Section 7. 
 
 
2. Blood glucose prediction research  
 
 Blood glucose prediction research range from 
physiological, data-driven and hybrid approach [10]. 
The physiological approach relies on expert knowledge 
on insulin and glucose metabolism focusing on 
simulation models [11, 12, 13]. The main challenge of 
physiological models is the lack of generalization 
capability and need support from data for higher 
prediction performance. Data-driven approaches are 
mainly based on machine learning methods such as 
fuzzy logic and rule-based models [14], multi-modal 
approaches [15, 16] autoregressive models [17, 18], 
support vector machine [19] and artificial neural 
networks models [20]. The hybrid approach includes 
physiological models such as glucose digestion and 
absorption, insulin absorptions, exercise, and other 
events. Those physiological models pre-process related 
data and the results are used in a data-driven model. [21, 
22, 23]. 
     Although there are existing studies on blood glucose 
prediction, the accuracy of longer-term accuracy 
remains the main challenge for blood glucose prediction 
studies [4]. Prediction horizon (PH) has been used in the 
vast majority of the studies for evaluation processes. 
Existing studies show an increase in the PH leads to a 
deterioration in the accuracy of a given model [4]. 
However, PH is important to be considered because 
patients’ needs in deciding meals, physical activity, and 
other events happen over time. Therefore, both accuracy 
and PH need to be considered to best meet patients’ 
needs. However, existing research can only demonstrate 
high performance in 30 min PH but cannot meet the 
accuracy requirement for glycaemic control for a longer 
period. Therefore a 30 min PH is the most common 
value for blood glucose prediction but high accuracy in 
longer PH is needed. 
   Deep learning, which incorporates methods recently 
proved to outperform the already established 
methodologies [24]. It has led to significant progress in 
computer vision [25], disease diagnosis [26], and 
healthcare [27, 28]. Deep learning shows superior 
performance to traditional ML techniques due to this 
ability to automatically learn features with higher 
complexity and representations [29-32]. Recurrent 
Neural Networks (RNNs) have shown its capability in 
many applications with time series or sequential data, 
including machine translation [33, 34] and speech 
recognition [35]. One of the major challenges in 
designing systems using classical RNNs is their limited 
capacity to learn long-term dependencies, because of the 
vanishing or exploding gradient problem [36]. Recent 
deep RNNs incorporate mechanisms to address this 
problem [37], e.g. long-short-term memory (LSTM) 
which introduces the memory cell and forget gate into 
classical RNN network [38]. Furthermore, the state-of-
the-art LSTM variants such as bidirectional LSTM (Bi-
LSTM) [39], vanilla LSTM (V-LSTM) [40], stacked 
LSTM [41], convolutional LSTM (c-LSTM) [42] and 
convolutional neural network LSTM (CNN) [43] have 
shown more promising results for time series 
predictions [6] because of their capability of capturing 
rich information from complex time series data. In this 
research, we propose a deep learning blood glucose 
prediction model based on LSTM variants for improved 
prediction and clinical accuracy. 
 
3. LSTM variants based model for long-
term blood glucose forecasting 
 
3.1 LSTM  
Long short-term memory(LSTM) is a special kind of 
recurrent neural network architecture(RNN). It is widely 
used on problems based on time series data such as 
speech recognition, handwriting recognition, prediction 
in healthcare pathways, etc. Unlike ordinary RNN, 
LSTM is specialized at manipulating Long-Term 
dependencies because it employs the “remember” 
mechanism through a series of gates. This feature fits 
the scenario of the glucose prediction problem because 
the observation window could be quite long which 
makes other machine learning methods difficult to 
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handle. The equations for the forward pass of the LSTM 
unit are as follows. 
 
 
 
 
 
 
 
where the subscript t indexes the time step, the 
operator∘denotes the element-wise product. 
 
𝑥𝑡: input vector to the LSTM unit 
𝑓𝑡: forget gate's activation vector 
𝑖𝑡: input/update gate's activation vector 
𝑜𝑡: output gate's activation vector 
ℎ𝑡: hidden state vector also known as output vector of 
the LSTM unit 
𝑐𝑡: cell state vector 
W, U: weight matrices for input vectors and hidden 
vectors 
b: bias vector parameters 
 
The architecture of the vanilla LSTM for glucose 
prediction is illustrated in Figure 2, a sequence of 
glucose values are input into the RNN-LSTM network 
and the target value is predicted at the end of the 
sequence.  
 
 
Figure 2 Vanilla LSTM 
 
3.2 Stacked LSTM  
 
The success of deep neural networks attributes to its 
application of multiple layers. Each layer solves part of 
the task and altogether the complex network increases 
the representation power. We can also apply the same 
strategy on LSTM by adding more layers to make it 
deeper. The outcome of this idea is the so-called 
stacked-LSTM. As the name implies, it is an extension 
of the vanilla LSTM network by stacking a sequence of 
LSTM layers.  Figure 2 gives the architecture of 
stacked-LSTM, which has several LSTM 
layers(vertically). In operation, each LSTM layer 
outputs a sequence of vectors that will be used as the 
input of the subsequent LSTM layer.  
 
                       Figure 3 Stacked LSTM 
 
 
3.3 CNN-LSTM  
 
Due to the intensity of glucose data, we employ CNN  in 
order to better represent the latent features in the glucose 
series, combined with LSTM we have CNN-LSTM.  
CNN-LSTM is the combination of CNN layers and 
LSTM layers in order to take both advantages of CNN 
and LSTM. It is first designed for spatial inputs 
prediction problems like image sequence and video 
sequence prediction, recently it also has been applied in 
general time series prediction problems and acquired 
promising results. The architecture of CNN-LSTM as 
illustrated in Figure 4 includes Convolutional Neural 
Network(CNN) layers on feature extraction, a follow-up 
Max Pooling Layer for summarizing the most activated 
presence of a feature,  then a pile of LSTM layers to 
handle the sequence processing and finally a Fully-
Connected Layer before the output. 
 
 
Figure 4 CNN-LSTM 
 
3.4 ConvLSTM 
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ConvLSTM is another way to leverage both CNN  and 
LSTM. Instead of putting a CNN layer before the LSTM 
layer, ConvLSTM modifies the internal computation 
logic and convolution operation in the LSTM cell. In 
running time, ConvLSTM first read the input with the 
convolutional part and feed the output into each LSTM 
unit. The most obvious part exchanged in ConvLSTM is 
that convolution operations replace matrix 
multiplication. So we have, e.g. the forget gate becomes  
, where '*' 
denotes convolution. Other formulas listed in Section 
3.1 are updated in the same way. 
The structure of ConvLSTM presents as follows: 
 
 Figure 5 ConvLSTM  
 
The structure looks similar to vanilla LSTM except that 
the cells are replaced by ConvLSTM cells and the 
sequence is chunked and shaped to 3 dimensions to meet 
the needs of convolution calculation.  
 
4. Data and training 
 
The data in this paper comes from donated CGM data 
of the OpenAPS project [7,8,9].  The glucose values are 
recorded every 5 minutes. We selected twenty persons' 
datasets from youth and adult age groups respectively 
which have the most integrity in one period. The overall 
number of time points is 878k, of which 1/3 are reserved 
as test data. Regarding the setting of the training and 
target window, we consulted clinicians about their 
practice in evaluating patients' glucose history and make 
a decision as follows: The training sliding window sizes 
are 60 minutes and 120 minutes respectively as they 
demonstrated better performance than other window 
sizes. So the input represented with time steps is 12 and 
24. The prediction horizons are  30 minutes, 45 minutes 
and 60 minutes respectively. That gives the output 
length is 6,  9 and 12. There are limited missing values 
in the datasets, we filled them with linear interpolation 
The hardware for the training task includes 1 x 
NVIDIA Tesla V100 and   4vCPU 26G memory, e.g. 
The software that we used includes Pandas for data 
wrangling and Keras-LSTM library for training, the 
batch size is 128, the number of epochs is 100. 
 
 
5 Evaluation  
 
We evaluate the results from two perspectives. One is 
the statistical evaluation which we use root-mean-
squared-error(RMSE) to evaluate the prediction ability 
of the model. Another is the clinical accuracy 
evaluation which we employ the Clarke error analysis. 
 
RMSE is the square root of the average squared 
difference between predicted values and the actual 
values. In general, the lower this value means a better 
average prediction performance. The RMSE formation 
can be illustrated as follows: 
 
 
 
where 𝑦𝑘is the actual value and ?̂?𝑘is the predicted one. 
Although RMSE is widely used in the evaluation of time 
series prediction, it takes each value equally and only 
looks at the value difference. However, in medical 
practice like glucose management, different values may 
have significant difference in clinician outcome. Thus 
we introduce Clarke Error Grid analysis which pays 
more attention to the medical significance and amplify 
the prediction errors that could lead to risk treatments. 
As shown in figure 6, 7 and 8 of the error grids, the 
horizontal axis represents true blood glucose and the 
vertical axis represents predicted blood glucose by the 
model. Specifically, breaks down the true-predicted 
blood glucose value scatter plots into five clinical 
meaningful regions. The regions signify the degree of 
risk posed by the incorrect prediction.  
 
● Section A. Predicted blood glucose value is within 
20% of the actual blood glucose values. This means the 
prediction error has no effect on clinical action therefore 
these points are also called clinical accurate ones which 
are appropriate to lead to the interventions. 
● Section B. Predicted value is beyond 20% but would 
not lead to inappropriate treatment. The prediction error 
has little or no effect on clinical outcomes.  
● Section C. The points in this area indicate the 
prediction errors might indicate an unnecessary 
treatment. 
● Section D. The points in this area means the prediction 
errors will lead to a dangerous failure of detecting 
hypoglycemia and hyperglycemia 
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● Section E. The points in this area means the prediction 
error could lead to dangerous consequences and it will 
confuse the treatment of hypoglycemia and 
hyperglycemia. 
 
Of all the 5 sections, the percentage of A+B states how 
the prediction algorithm performs in a clinical 
acceptance way, while we should also be aware of C, D, 
and E which symbolizes the errors that may lead to miss 
judgment in treatments. More percentage in A means 
less errors thus more clinically accurate predictions. 
 
6. Results 
6.1 Prediction accuracy in RMSE 
We compared the performance among LSTM variants 
based models and support vector regression (SVR) 
method as the baseline. Table 1 shows the blood glucose 
prediction accuracy of CNN, v-LSTM, CNN-LSTM 
convLSTM and SVR over the prediction horizon of 30, 
45 and 60 minutes. We notice that stacked-LSTM gives 
the best RMSE performance under the short-term(30 
minutes) and mid-term(45 minutes) horizon. Vanilla-
LSTM has the lowest score on long-term(60 minutes) 
horizon prediction. However, vanilla-LSTM only 
outperforms stacked-LSTM with 0.1 difference(19.01 
vs 19.24) .If we consider the overall performance on all 
prediction horizons, stacked-LSTM achieves the best 
score. Besides, all the LSTM variant models outperform 
SVR in 30, 45 and 60 prediction horizons. 
 
Table 1 Blood Glucose Prediction Accuracy 
comparison in RMSE 
Method\PH(
min) 
30 min  45 min  60 min 
CNN 14.74±1.06 18.08±1.94 21.04±2.45 
vanilla-
LSTM 
12.33±1.15 15.86±1.80 19.01±2.62 
stacked-
LSTM 
11.96±1.02 15.81±1.56 19.24±1.78 
CNN-LSTM 13.05±1.21 16.72±2.28 19.80±2.54 
convLSTM 12.20±0.94 15.82±1.85 19.60±2.01 
SVR 13.28±1.02 17.89±1.34 24.21±2.96 
 
 
6.2 Clinical Accuracy 
 
In addition to prediction accuracy, we also evaluated the 
clinical accuracy using the Clarke Error analysis to 
understand the clinical value of the proposed methods. 
Table 2 shows the score of Clarke zone A and zone B of 
CNN, v-LSTM, bi-LSTM, s-LSTM, CNN-LSTM, 
convLSTM and SVR over 30 minutes, 45 minutes and 
60 minutes prediction horizon.    
 
Table 2 The Clinical Accuracy from Clarke Error 
Analysis  
Method\
PH(min) 
30 min 45 min 60 min 
Azo
ne 
Bzon
e 
Azone Bzon
e 
Azone Bzone 
CNN 0.84
4 
0.124 0.732 0.230 0.652 0.304 
vanilla-
LSTM 
0.87
1 
0.108 0.782 0.182 0.650 0.309 
stacked-
LSTM 
0.88
7 
0.089 0.784 0.181 0.700 0.250 
CNN-
LSTM 
0.86
1 
0.110 0.748 0.214 0.700 0.257 
convLST
M 
0.86
8 
0.102 0.782 0.182 0.713 0.245 
SVR 0.80
4 
0.107 0.703 0.180 0.645 0.213 
 
 
We can learn that all methods have a high clinical 
acceptance rate because the total score of zone A and B 
for each LSTM variant based model has an average 
above 0.95. When we look at the long term prediction 
accuracy, convLSTM gives the best performance with 
zone A score of 0.713 in 60 minutes prediction horizon. 
Stacked-LSTM shows the best performance in 30 and 
45 minutes prediction horizons with Clarke zone A 
score of 0.887 and 0.784 respectively. Figure 6-8 
illustrates points distribution of the best  prediction on 
Clarke Grid Analysis on 60 minutes, 45 minutes, and 30 
minutes prediction horizons respectively. It’s clear that 
the majority of points spread in ZoneA+B which is good 
to lead the treatment. When we look at Zone C-D, 
compared with zone-C, points zone-D develops fast as 
the target horizon increases from 30 minutes to 60 
minutes. It indicates that the failure of detecting 
hypoglycemia and hyperglycemia increases as we 
predict farther in the future. That is one potential 
orientation for optimization. 
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    Figure 6  Clarke Error of convLSTM on PH 60(min) 
 
 
    Figure 7 Clarke Error of Stacked LSTM on PH 
45(min) 
 
 
 
    Figure 8 Clarke Error of Stacked LSTM on PH 
30(min) 
 
7. Conclusion  
 
In this paper, we developed LSTM variants based blood 
glucose prediction models for improved prediction and 
clinical accuracy in long prediction horizon. The 
modified LSTM can capture more long-term 
dependencies due to deeper architecture and learn to 
remove background noise, outline important features 
and better captures both future and past context of the 
input sequence. We evaluate the prediction and clinical 
accuracy of the long term (above 30 minutes) of the 
proposed methods using 20 cases of real-life data from 
OpenAPS community. Prediction results were 
compared between LSTM variants and to those 
established learning algorithms and widely used 
algorithms applied to the real-time prediction of glucose 
using CGM data. Prediction Horizons (PH) of 30, 45, 
and 60 minutes were used. The proposed LSTM variant 
based methods showed superior performance in 
forecasting BG levels (RMSE and clinical accuracy) 
against existing methods. For several other works, it is 
difficult to evaluate the RMSE through direct 
comparison due to the availability of benchmark 
datasets. However, we may compare the results with 
widely used methods as benchmarks, such as SVR. The 
results show that our approach suggests superiority in 
their prediction accuracy over the 30, 45, and 60 minute 
time period than existing studies [43][46]. As far as we 
know, the proposed algorithm achieves a performance 
state-of-the-art accuracy with regard to RMSE and 
clinical accuracy. 
 
There are several limitations and future work for this 
research. First, the longest prediction horizon evaluated 
is 60 minutes and future work will further improve the 
proposed models for longer term prediction towards 
more than 4 hours. Second, future life events will be 
considered over the longer prediction horizons to 
improve the performance. A hybrid model combining 
the advantages of both physiological and LSTM based 
approach could be developed. Thirdly, there is timing 
effects that users of OpenAPS have DIY systems 
making insulin dosing adjustments and acting upon 
them so it will affect the prediction results. We will 
consider quantify these influences and make the 
prediction more accurate. Although some works suggest 
that ingested carbohydrate information, along with 
injected insulin information might be redundant [44, 
45], we will in future incorporate more clinical 
information such as comorbidities and other information 
from Electronic Patient Record for detailed patients 
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phenotyping and personalized prediction model 
development. Finally, we have demonstrated the 
application of deep learning based blood glucose 
prediction model in the real-life data but more data from 
both OpenAPS and patients under various closed-loop 
system could reflect a wider population.  
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